FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2761556513> ?p ?o ?g. }

• W2761556513 endingPage "2945" @default.
• W2761556513 startingPage "2937" @default.
• W2761556513 abstract "Short vs prolonged dual antiplatelet treatment upon endovascular stenting of peripheral arteries Mariya Kronlage,1 Maximilian Wassmann,1 Britta Vogel,1 Oliver J Müller,1 Erwin Blessing,2 Hugo Katus,1,3 Christian Erbel1 1Department of Cardiology, Angiology and Pneumology, University Hospital Heidelberg, Heidelberg, 2SRH Klinikum Karlsbad Langensteinbach, Karlsbad, 3DZHK German Center for Cardiovascular Research, Partner Site Heidelberg/Mannheim, Mannheim, Germany Introduction: Peripheral artery disease (PAD) is a highly prevalent disorder with a substantial economical burden. Dual antiplatelet treatment (DAPT) upon endovascular stenting to prevent acute thrombotic reocclusions is an universally accepted practice for postinterventional management of PAD patients. However, the optimal period of time for DAPT upon endovascular stenting is not known.Methods: In the current nonrandomized, retrospective monocentric study, we evaluated the duration of DAPT upon endovascular stenting. A total of 261 endovascular SFA and iliac stenting procedures were performed on 214 patients and these patients were subdivided into a short (4–6 weeks) or a prolonged (8–12 weeks) DAPT regime group. More than 65% of the patients included were male, approximately 35% were diabetic, and 61% had a history of smoking. Of all the patients, 90% exhibited a Rutherford stage 2–3, and approximately half of the patients had a moderate-to-severe calcified target lesion with a length of >13 cm. Major safety end points were defined as any bleeding, compartment syndrome, and ischemic events. In addition to this, patency, all-cause mortality, as well as amputation were followed up over a period of 12 months upon intervention.Results: Twelve months after endovascular stenting, primary patency in our cohort was comparable between the groups (83.94% short vs 79.8% long DAPT, P>0.05). Major bleeding occurred in 18 cases without any difference between the groups (P>0.05). In addition, during the 12-month follow-up, 6 (3.4%) patients in the short and 3 (3.5%) in the prolonged DAPT regime suffered a stroke/transient ischemic attack (P>0.05). In addition, there was no difference regarding mortality and amputation rate comparing short vs prolonged DAPT regime in a 12-month follow-up.Conclusion: In the current cohort, prolonged DAPT after endovascular stenting had no beneficial effect on the outcome in a 12-month follow-up. Keywords: peripheral artery disease, stent implantation, dual antiplatelet therapy, primary patency, endovascular therapy" @default.
• W2761556513 created "2017-10-20" @default.
• W2761556513 creator A5010518110 @default.
• W2761556513 creator A5020918009 @default.
• W2761556513 creator A5037675983 @default.
• W2761556513 creator A5049262839 @default.
• W2761556513 creator A5058583100 @default.
• W2761556513 creator A5069966461 @default.
• W2761556513 creator A5070548943 @default.
• W2761556513 date "2017-10-01" @default.
• W2761556513 modified "2023-10-16" @default.
• W2761556513 title "Short vs prolonged dual antiplatelet treatment upon endovascular stenting of peripheral arteries" @default.
• W2761556513 cites W1480729244 @default.
• W2761556513 cites W1501701126 @default.
• W2761556513 cites W1977671695 @default.
• W2761556513 cites W1983722147 @default.
• W2761556513 cites W2008836245 @default.
• W2761556513 cites W2008850799 @default.
• W2761556513 cites W2011372737 @default.
• W2761556513 cites W2020272031 @default.
• W2761556513 cites W2024352468 @default.
• W2761556513 cites W2028305802 @default.
• W2761556513 cites W2033750122 @default.
• W2761556513 cites W2037500444 @default.
• W2761556513 cites W2042051913 @default.
• W2761556513 cites W2042123703 @default.
• W2761556513 cites W2089946259 @default.
• W2761556513 cites W2100089051 @default.
• W2761556513 cites W2100209149 @default.
• W2761556513 cites W2108525796 @default.
• W2761556513 cites W2110361452 @default.
• W2761556513 cites W2115824015 @default.
• W2761556513 cites W2123874951 @default.
• W2761556513 cites W2126460637 @default.
• W2761556513 cites W2147137884 @default.
• W2761556513 cites W2150740314 @default.
• W2761556513 cites W2165349656 @default.
• W2761556513 cites W2166109718 @default.
• W2761556513 cites W2177951737 @default.
• W2761556513 cites W2332559082 @default.
• W2761556513 cites W2341068520 @default.
• W2761556513 cites W2407388140 @default.
• W2761556513 cites W2430015321 @default.
• W2761556513 cites W2431546415 @default.
• W2761556513 cites W2546593435 @default.
• W2761556513 cites W2556414715 @default.
• W2761556513 cites W2556838984 @default.
• W2761556513 cites W2556919357 @default.
• W2761556513 cites W2753407454 @default.
• W2761556513 cites W2887208783 @default.
• W2761556513 cites W311320695 @default.
• W2761556513 cites W4236531408 @default.
• W2761556513 cites W4246778063 @default.
• W2761556513 doi "https://doi.org/10.2147/dddt.s143226" @default.
• W2761556513 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5638576" @default.
• W2761556513 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29062225" @default.
• W2761556513 hasPublicationYear "2017" @default.
• W2761556513 type Work @default.
• W2761556513 sameAs 2761556513 @default.
• W2761556513 citedByCount "6" @default.
• W2761556513 countsByYear W27615565132019 @default.
• W2761556513 countsByYear W27615565132020 @default.
• W2761556513 countsByYear W27615565132021 @default.
• W2761556513 countsByYear W27615565132022 @default.
• W2761556513 crossrefType "journal-article" @default.
• W2761556513 hasAuthorship W2761556513A5010518110 @default.
• W2761556513 hasAuthorship W2761556513A5020918009 @default.
• W2761556513 hasAuthorship W2761556513A5037675983 @default.
• W2761556513 hasAuthorship W2761556513A5049262839 @default.
• W2761556513 hasAuthorship W2761556513A5058583100 @default.
• W2761556513 hasAuthorship W2761556513A5069966461 @default.
• W2761556513 hasAuthorship W2761556513A5070548943 @default.
• W2761556513 hasBestOaLocation W27615565131 @default.
• W2761556513 hasConcept C126322002 @default.
• W2761556513 hasConcept C141071460 @default.
• W2761556513 hasConcept C164705383 @default.
• W2761556513 hasConcept C2777849778 @default.
• W2761556513 hasConcept C500558357 @default.
• W2761556513 hasConcept C555175668 @default.
• W2761556513 hasConcept C71924100 @default.
• W2761556513 hasConceptScore W2761556513C126322002 @default.
• W2761556513 hasConceptScore W2761556513C141071460 @default.
• W2761556513 hasConceptScore W2761556513C164705383 @default.
• W2761556513 hasConceptScore W2761556513C2777849778 @default.
• W2761556513 hasConceptScore W2761556513C500558357 @default.
• W2761556513 hasConceptScore W2761556513C555175668 @default.
• W2761556513 hasConceptScore W2761556513C71924100 @default.
• W2761556513 hasLocation W27615565131 @default.
• W2761556513 hasLocation W27615565132 @default.
• W2761556513 hasLocation W27615565133 @default.
• W2761556513 hasLocation W27615565134 @default.
• W2761556513 hasOpenAccess W2761556513 @default.
• W2761556513 hasPrimaryLocation W27615565131 @default.
• W2761556513 hasRelatedWork W1983829728 @default.
• W2761556513 hasRelatedWork W2030906043 @default.
• W2761556513 hasRelatedWork W2236042039 @default.
• W2761556513 hasRelatedWork W2316719883 @default.
• W2761556513 hasRelatedWork W2763747986 @default.

• next